Last Posted: Dec 09, 2018
- Communication About Hereditary Cancers on Social Media: A Content Analysis of Tweets About Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
Allen Caitlin G et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2018 Dec - A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study.
Nunziato Marcella et al. Analytica chimica acta 2019 Jan 1046154-162 - Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Frey Melissa K et al. Cancer 2018 Nov - Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.
Terry Mary Beth et al. Journal of the National Cancer Institute 2018 Nov - Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
Laitman Yael et al. Cancer 2018 Nov - Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy.
Harris Faye R et al. Molecular oncology 2018 Nov - The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.
Bernstein-Molho Rinat et al. Cancer causes & control : CCC 2018 Nov - Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.
Singer Christian F et al. European journal of cancer (Oxford, England : 1990) 2018 Nov 10654-60 - No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
Jacobson Michelle et al. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018 Nov 40(11) 1497-1510 - Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.
Santana Dos Santos Elizabeth et al. Cancers 2018 Nov 10(11)
.png)
No hay comentarios:
Publicar un comentario